Pneumonia & Flu
Countries are narrowing in on a “deal to speed up their response to the next flu pandemic by sharing virus samples in return for access to affordable vaccines,” co-chairs of a WHO working group told reporters on Tuesday, Reuters reports. The group, which is meeting this week and just last week was in meetings with drug manufacturers and WHO member states about the plans, says it hopes to have a draft agreement finalized by Friday to be voted on during next month’s World Health Assembly, according to the news service (Nebehay, 4/12).
Also In Global Health News: Potential Corruption With DFID Funds; HIV/AIDS In Tanzania; Drug Substitution Program In Afghanistan; Rare Disease Consortium; Pnuemonococcal Vaccine In DRC
U.K.’s National Audit Office Warns DFID To Be On Guard Against Possible Corruption The U.K.’s National Audit Office (NAO) on Wednesday issued a report on the financial management of the Department for International Development (DFID) warning that “the UK had no clear picture of the ‘extent, nature and impact’ of…
WHO Director-General Margaret Chan on Monday responded to the first results of a probe into the agency’s response to the H1N1 (swine flu) pandemic, Agence France-Presse reports. While calling attention to where the external panel committee commended the agency’s actions, Chan also addressed the criticisms and recommendations issued in the draft report (3/28). Her comments came as the review committee held its “fourth and final public session” in Geneva to receive “feedback from countries and organizations on its preliminary report,” CIDRAP News reports (Schnirring, 3/28).
Health officials in Venezuela announced on Friday the number of confirmed H1N1 (swine flu) cases in the country has grown to more than 200, the Associated Press/Seattle Times reports (3/25).
On the heels of the release of a draft report by an independent panel of experts examining the WHO’s response to H1N1 (swine flu), BMJ News reports on a recently approved resolution and accompanying report released by the European Union parliament that calls on EU countries to revise their flu prevention plans “to make them more effective, coherent, and flexible” and for the WHO to revise its definition of pandemic to take into account not only geographical spread of disease but also severity.
An independent panel of experts commissioned by the WHO to probe its response to the H1N1 (swine flu) pandemic on Thursday released a draft report (.pdf) stating that while the organization performed well in many ways, it made “crucial mistakes” and “warned tens of millions could die if there is a severe flu outbreak in the future,” the Associated Press reports (3/10).
Lancet Infectious Diseases Examines How Resource Gaps Are Creating Barriers To Reduce Child Mortality
The Lancet Infectious Diseases’ Newsdesk examines how resource gaps in immunizations, health workers and financing are creating barriers to efforts to achieve the U.N. Millennium Development Goal (MDG) target to reduce child mortality by two-thirds by 2015, as highlighted in a recent Save the Children report. The article describes the role GAVI Alliance has played in increasing the number of children receiving vaccines worldwide and notes the $3.7 billion gap the group hopes to fill to expand its immunization campaign over the next four years.
Also In Global Health News: Faster Technology For Creating Flu Vaccines; Ukraine’s ARV Shortages; Testing University Students For HIV In SA; Polio Eradication; Haiti Housing Plan; Women’s Shelters In Afghanistan
Researchers FindÂ Flu Vaccine Created Using Faster Technique As Effective As Traditional Vaccine A seasonal flu vaccine “made using quicker cell-based manufacturing methods was at least as effective at preventing flu as conventional vaccines grown in chicken eggs,” researchers reported Tuesday in the journal Lancet, Reuters reports. The clinical trial, conducted…
On Monday, the same day the GAVI Alliance helped oversee the roll out of a routine pneumococcal vaccine in Kenya, GAVI chairman Dagfinn Hoybraten highlighted the need for greater reductions in vaccine prices in developing countries during an interview with Reuters, the news service reports. The piece examines the funding mechanism in place to finance the pneumococcal vaccines, known as Advance Market Commitment (AMC), as well as the budget shortfall facing the group (Kelland, 2/14).